Foster Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Foster Group's BMY Position: Q3 2026 in Review
Foster Group increased its Bristol-Myers Squibb (BMY) stake by 6.3% in Q3 2026, buying an estimated $17K and bringing the position to 4,550 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #254.
Foster Group first reported a position in BMY in Q4 2020 and has held it in 20 quarters since. The position peaked at $499K in Q4 2022. 474 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Foster Group held 4,550 shares of Bristol-Myers Squibb worth $284K as of Q3 2026.
- Foster Group bought 269 Bristol-Myers Squibb shares in Q3 2026, an estimated $17K.
- Bristol-Myers Squibb made up 0.01% of Foster Group's portfolio in Q3 2026, its #254 holding.
- Foster Group first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 20 quarters since.
- Foster Group's Bristol-Myers Squibb position peaked at $499K in Q4 2022.
- 474 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Foster Group's 13F filing for Q3 2026, filed 13 Oct 2026.